Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Haemdates-XT
- Development stage
- Unknown
- Lead developer
- Kaiser Pharmaceuticals
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Haemdates-XT is a branded generic oral hematinic supplement manufactured by Kaiser Pharmaceutical (Kaiser Drugs Pvt Ltd). It is typically formulated as a combination of ferrous ascorbate and folic acid. Ferrous ascorbate is a synthetic conjugate of ferrous iron and ascorbic acid that provides a highly bioavailable source of elemental iron with reduced gastrointestinal side effects compared to traditional iron salts. Folic acid (Vitamin B9) is an essential cofactor for DNA synthesis and the maturation of red blood cells. Haemdates-XT is indicated for the treatment and prevention of iron deficiency anemia and folic acid deficiency, particularly during pregnancy, lactation, and recovery from surgery or chronic illness.
- Brand names
- Haemdates-XTHaemdates XT Tablet
- Other names
- Haemdates Syrup
02
Targets
DHFR (Dihydrofolate reductase)
Beyond the preview
Go deeper on Haemdates-XT.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Haemdates-XT.